Genomics Unlocked background
Genomics Unlocked Logo

GENOMICS UNLOCKED

Discover the boundless realm of genomic webinars.
Genomics Unlocked background
Genomics Unlocked Logo

GENOMICS UNLOCKED

Discover the boundless realm of genomic webinars.

Welcome to Genomics Unlocked

Welcome to Genomics Unlocked

Welcome to Genomics Unlocked

Welcome to Genomics Unlocked

Dive deep with us into the fascinating world of genomic science. Experience the revolution of genomics applications through a series of webinars driven by top scientists.

Dive deep with us into the fascinating world of genomic science. Experience the revolution of genomics applications through a series of webinars driven by top scientists.

Our Collaborations

Catch up on our latest webinar

Transforming Clinical Diagnostics, DNBSEQ-T7: Your gateway to Whole Genome Sequencing

Transforming Clinical Diagnostics

Apr 24, 2024

07:00 - 09:00 am BST

Share

Whole Genome Sequencing (WGS) is revolutionizing oncological research and treatment by providing a detailed view of the genomic alterations associated with cancer. Inocras’s Cancer Vision platform utilizes WGS to transform DNA data intoaction.

This talk will focus on the clinical applications of WGS, illustrating its utility in real-world settings. We aim to explore how these WGS-powered genomic insights facilitate a deeper understanding of tumor biology and aid in personalized treatment strategies.

We will examine the integration of WGS into clinical practice, discussing specific cases and studies where WGS has aided clinical decisions. Key topics will include the detection of rare and complex mutations, the identification of actionable targets for therapy, and the role of WGS in identifying genomic signatures. The utilization of WGS in clinical oncology offers a transformative approach to cancer care, enabling a shift toward a more tailored treatment strategy.

Dr. Erin Connolly-Strong 

Dr. Erin Connolly-Strong Chief Medical Officer @Inocras

Register

Register

Catch up on our latest webinar

Transforming Clinical Diagnostics, DNBSEQ-T7: Your gateway to Whole Genome Sequencing

Transforming Clinical Diagnostics

Apr 24, 2024

07:00 - 09:00 am BST

Share

Whole Genome Sequencing (WGS) is revolutionizing oncological research and treatment by providing a detailed view of the genomic alterations associated with cancer. Inocras’s Cancer Vision platform utilizes WGS to transform DNA data intoaction.

This talk will focus on the clinical applications of WGS, illustrating its utility in real-world settings. We aim to explore how these WGS-powered genomic insights facilitate a deeper understanding of tumor biology and aid in personalized treatment strategies.

We will examine the integration of WGS into clinical practice, discussing specific cases and studies where WGS has aided clinical decisions. Key topics will include the detection of rare and complex mutations, the identification of actionable targets for therapy, and the role of WGS in identifying genomic signatures. The utilization of WGS in clinical oncology offers a transformative approach to cancer care, enabling a shift toward a more tailored treatment strategy.

Dr. Erin Connolly-Strong 

Dr. Erin Connolly-Strong Chief Medical Officer @Inocras

Register

Register

Catch up on our latest webinar

Transforming Clinical Diagnostics, DNBSEQ-T7: Your gateway to Whole Genome Sequencing

Transforming Clinical Diagnostics

Apr 24, 2024

07:00 - 09:00 am BST

Share

Whole Genome Sequencing (WGS) is revolutionizing oncological research and treatment by providing a detailed view of the genomic alterations associated with cancer. Inocras’s Cancer Vision platform utilizes WGS to transform DNA data intoaction.

This talk will focus on the clinical applications of WGS, illustrating its utility in real-world settings. We aim to explore how these WGS-powered genomic insights facilitate a deeper understanding of tumor biology and aid in personalized treatment strategies.

We will examine the integration of WGS into clinical practice, discussing specific cases and studies where WGS has aided clinical decisions. Key topics will include the detection of rare and complex mutations, the identification of actionable targets for therapy, and the role of WGS in identifying genomic signatures. The utilization of WGS in clinical oncology offers a transformative approach to cancer care, enabling a shift toward a more tailored treatment strategy.

Dr. Erin Connolly-Strong 

Dr. Erin Connolly-Strong Chief Medical Officer @Inocras

Register

Register

Catch up on our latest webinar

Transforming Clinical Diagnostics, DNBSEQ-T7: Your gateway to Whole Genome Sequencing

Transforming Clinical Diagnostics

Apr 24, 2024

07:00 - 09:00 am BST

Share

Whole Genome Sequencing (WGS) is revolutionizing oncological research and treatment by providing a detailed view of the genomic alterations associated with cancer. Inocras’s Cancer Vision platform utilizes WGS to transform DNA data intoaction.

This talk will focus on the clinical applications of WGS, illustrating its utility in real-world settings. We aim to explore how these WGS-powered genomic insights facilitate a deeper understanding of tumor biology and aid in personalized treatment strategies.

We will examine the integration of WGS into clinical practice, discussing specific cases and studies where WGS has aided clinical decisions. Key topics will include the detection of rare and complex mutations, the identification of actionable targets for therapy, and the role of WGS in identifying genomic signatures. The utilization of WGS in clinical oncology offers a transformative approach to cancer care, enabling a shift toward a more tailored treatment strategy.

Dr. Erin Connolly-Strong 

Dr. Erin Connolly-Strong Chief Medical Officer @Inocras

Register

Register

On Demand, Offering You Access
Whenever You Need It.

On Demand, Offering You Access
Whenever You Need It.

On Demand, Offering You Access
Whenever You Need It.

All your greatest webinars and expert speakers at the tip of your fingers.

All your greatest webinars and expert speakers at the tip of your fingers.

All your greatest webinars and expert speakers at the tip of your fingers.

  • Comprehensive Molecular Tumor Analysis (CMTA) integrating RNAseq and TME for targeted therapy

    This webinar delves into Alacris Theranostics' CMTA, merging whole exome and transcriptome sequencing to steer targeted cancer treatments. Ideal for intricate tumors, it employs MGI DNBSEQ technology for personalized care. Speakers: Dr. Marie-Laure Yaspo, Alacris Theranostics; Priyanka Kurapati, MGI-tech.

    Comprehensive Molecular Tumor Analysis (CMTA) integrating RNAseq and TME for targeted therapy
  • SpaTial Enhanced REsolution Omics-sequencing New Frontiers of Spatial Multi-omics

    Stereo-seq, based on DNA Nanoball technology, offers spatially resolved single-cell gene expression in tissue slices. This webinar explores its potential in the Human Protein Atlas program, enhancing coverage, resolution, and providing intuitive bioinformatic tools. Speakers: Dr. Jan Mulder, Karolinska Institute; Dr. Yen-Yu Lin, BGI Research.

  • Revolutionizing Agriculture, Harnessing The Power of Genomics

    Discover how Next-Generation Sequencing revolutionizes agriculture, enhancing plant and animal breeding. Case studies highlight NGS's role in streamlining selection for quicker, economical breeding. Speakers: Prof. Robert Henry, QAAFI; Prof. Xiaolei Liu, Glibizzia Biosciences; Dr. Shangtong Li, Huazhong Agricultural University.

    Harnessing The Power of Genomics
  • Immune Repertoire Profiling with DNBSEQ

    MGI's DNBSEQ™ technology offers enhanced sequencing, boasting low error rates and broad library method compatibility. It elevates genomics in health monitoring and deepens genomic understanding, making high-throughput sequencing both quality-driven and cost-effective. Speaker: Dr. Weilin Liu, MGI.

    Immune Repertoire Profiling with DNBSEQ
  • Clinical Exome Sequencing to reporting

    Explore a full disease diagnosis workflow, from sample gathering to report creation. Delve into exome sequencing with MGI’s DNBSeq-T7, data interpretation via VarSome Clinical, and Gencell's hands-on tool application. Speakers: Prof. Charles E. Chappel, Saphetor; Dr. Marcela Galvez, Gencell; Dr. Manuel Delpero, MGI.

    Clinical Exome Sequencing to reporting
  • Whole Exome Sequencing with DNBSEQ

    Uncover NoorDx's transformation of high-throughput DNA sequencing into a pivotal diagnostic instrument in Saudi Arabia using MGI platforms, emphasizing genome analysis's role in healthcare choices. Speakers: Dr. Ashraf Dallol, NoorDx; Dr. Akbar Ali Khan Pathan, MGI

    Whole Exome Sequencing with DNBSEQ
  • Comprehensive Molecular Tumor Analysis (CMTA) integrating RNAseq and TME for targeted therapy

    This webinar delves into Alacris Theranostics' CMTA, merging whole exome and transcriptome sequencing to steer targeted cancer treatments. Ideal for intricate tumors, it employs MGI DNBSEQ technology for personalized care. Speakers: Dr. Marie-Laure Yaspo, Alacris Theranostics; Priyanka Kurapati, MGI-tech.

    Comprehensive Molecular Tumor Analysis (CMTA) integrating RNAseq and TME for targeted therapy
  • Immune Repertoire Profiling with DNBSEQ

    MGI's DNBSEQ™ technology offers enhanced sequencing, boasting low error rates and broad library method compatibility. It elevates genomics in health monitoring and deepens genomic understanding, making high-throughput sequencing both quality-driven and cost-effective. Speaker: Dr. Weilin Liu, MGI.

    Immune Repertoire Profiling with DNBSEQ
  • SpaTial Enhanced REsolution Omics-sequencing New Frontiers of Spatial Multi-omics

    Stereo-seq, based on DNA Nanoball technology, offers spatially resolved single-cell gene expression in tissue slices. This webinar explores its potential in the Human Protein Atlas program, enhancing coverage, resolution, and providing intuitive bioinformatic tools. Speakers: Dr. Jan Mulder, Karolinska Institute; Dr. Yen-Yu Lin, BGI Research.

  • Clinical Exome Sequencing to reporting

    Explore a full disease diagnosis workflow, from sample gathering to report creation. Delve into exome sequencing with MGI’s DNBSeq-T7, data interpretation via VarSome Clinical, and Gencell's hands-on tool application. Speakers: Prof. Charles E. Chappel, Saphetor; Dr. Marcela Galvez, Gencell; Dr. Manuel Delpero, MGI.

    Clinical Exome Sequencing to reporting
  • Revolutionizing Agriculture, Harnessing The Power of Genomics

    Discover how Next-Generation Sequencing revolutionizes agriculture, enhancing plant and animal breeding. Case studies highlight NGS's role in streamlining selection for quicker, economical breeding. Speakers: Prof. Robert Henry, QAAFI; Prof. Xiaolei Liu, Glibizzia Biosciences; Dr. Shangtong Li, Huazhong Agricultural University.

    Harnessing The Power of Genomics
  • Whole Exome Sequencing with DNBSEQ

    Uncover NoorDx's transformation of high-throughput DNA sequencing into a pivotal diagnostic instrument in Saudi Arabia using MGI platforms, emphasizing genome analysis's role in healthcare choices. Speakers: Dr. Ashraf Dallol, NoorDx; Dr. Akbar Ali Khan Pathan, MGI

    Whole Exome Sequencing with DNBSEQ
  • Harnessing The Power of Genomics
  • Comprehensive Molecular Tumor Analysis (CMTA) integrating RNAseq and TME for targeted therapy
  • OncoPanels with DNBSEQ
  • Building the Largest Database of Human Microbiomes
  • Clinical Exome Sequencing to reporting
  • Whole Exome Sequencing with DNBSEQ
  • Immune Repertoire Profiling with DNBSEQ
  • Closing the Cancer Care Gap with the Power of Precision Oncology
Genomics Unlocked Background

Join our newsletter to stay up to date on our latest webinars.

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.

Genomics Unlocked Background

Join our newsletter to stay up to date on our latest webinars.

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.

Genomics Unlocked Background

Join our newsletter to stay up to date on our latest webinars.

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.

Genomics Unlocked Background

Join our newsletter to stay up to date on our latest webinars.

Copyright © 2024 MGI tech GmbH, Ltd. All Rights Reserved.